Jpmorgan Chase & CO Vbi Vaccines Inc Transaction History

Jpmorgan Chase & CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 18, 2023	BUY	$0.29 - $0.64 $42,833 - $94,529	147,702 Added 68.89%	362,113 $108,000
Q1 2023 May 11, 2023	SELL	$0.29 - $0.64 $8,242 - $18,191	-28,424 Reduced 11.71%	214,411 $64,000
Q4 2022 Feb 13, 2023	BUY	$0.38 - $22.5 $51,347 - $3.04 Million	135,125 Added 125.45%	242,835 $95,000
Q3 2022 Nov 14, 2022	BUY	$0.73 - $23.4 $1,551 - $49,748	2,126 Added 2.01%	107,710 $76,000
Q2 2022 Aug 11, 2022	SELL	$0.66 - $1.81 $8,092 - $22,194	-12,262 Reduced 10.41%	105,584 $85,000
Q1 2022 May 11, 2022	BUY	$1.27 - $2.47 $55,137 - $107,235	43,415 Added 58.33%	117,846 $196,000
Q4 2021 Feb 10, 2022	SELL	$2.21 - $3.22 $304,301 - $443,371	-137,693 Reduced 64.91%	74,431 $174,000
Q3 2021 Nov 12, 2021	BUY	$2.8 - $3.72 $593,947 - $789,101	212,124 New	212,124 $659,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.